nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Mesalazine—Crohn's disease	0.438	1	CrCtD
Salicylate-sodium—PTGS2—Crohn's disease	0.126	1	CbGaD
Salicylate-sodium—Salicylamide—Mesalazine—Crohn's disease	0.1	0.515	CrCrCtD
Salicylate-sodium—Salicylic acid—Mesalazine—Crohn's disease	0.0943	0.485	CrCrCtD
Salicylate-sodium—PTGS2—Balsalazide—Crohn's disease	0.0539	0.241	CbGbCtD
Salicylate-sodium—PTGS1—Balsalazide—Crohn's disease	0.0455	0.204	CbGbCtD
Salicylate-sodium—PTGS2—Mesalazine—Crohn's disease	0.0431	0.193	CbGbCtD
Salicylate-sodium—PTGS1—Mesalazine—Crohn's disease	0.0364	0.163	CbGbCtD
Salicylate-sodium—PTGS2—Sulfasalazine—Crohn's disease	0.0241	0.108	CbGbCtD
Salicylate-sodium—PTGS1—Sulfasalazine—Crohn's disease	0.0203	0.0911	CbGbCtD
Salicylate-sodium—Intestinal perforation—Azathioprine—Crohn's disease	0.000553	0.0343	CcSEcCtD
Salicylate-sodium—Alkalosis—Prednisone—Crohn's disease	0.000525	0.0326	CcSEcCtD
Salicylate-sodium—Water retention—Prednisone—Crohn's disease	0.000464	0.0288	CcSEcCtD
Salicylate-sodium—Distention—Prednisone—Crohn's disease	0.000447	0.0278	CcSEcCtD
Salicylate-sodium—Abdominal bloating—Mesalazine—Crohn's disease	0.000418	0.026	CcSEcCtD
Salicylate-sodium—Duodenal ulcer—Mesalazine—Crohn's disease	0.000412	0.0256	CcSEcCtD
Salicylate-sodium—Ulcer—Mercaptopurine—Crohn's disease	0.000388	0.0241	CcSEcCtD
Salicylate-sodium—Sepsis—Mercaptopurine—Crohn's disease	0.000318	0.0198	CcSEcCtD
Salicylate-sodium—Upset stomach—Mesalazine—Crohn's disease	0.000304	0.0189	CcSEcCtD
Salicylate-sodium—Intestinal obstruction—Mesalazine—Crohn's disease	0.000292	0.0181	CcSEcCtD
Salicylate-sodium—Mesalazine—MPO—Crohn's disease	0.000291	0.258	CrCbGaD
Salicylate-sodium—Burning sensation—Mesalazine—Crohn's disease	0.000287	0.0178	CcSEcCtD
Salicylate-sodium—Gastric irritation—Prednisone—Crohn's disease	0.000272	0.0169	CcSEcCtD
Salicylate-sodium—Feeling hot—Mesalazine—Crohn's disease	0.000254	0.0157	CcSEcCtD
Salicylate-sodium—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000229	0.137	CbGpPWpGaD
Salicylate-sodium—Tenderness—Mesalazine—Crohn's disease	0.000228	0.0142	CcSEcCtD
Salicylate-sodium—Hypocalcaemia—Mesalazine—Crohn's disease	0.000218	0.0135	CcSEcCtD
Salicylate-sodium—Hypernatraemia—Prednisone—Crohn's disease	0.0002	0.0124	CcSEcCtD
Salicylate-sodium—Epigastric discomfort—Prednisone—Crohn's disease	0.0002	0.0124	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Mesalazine—Crohn's disease	0.00019	0.0118	CcSEcCtD
Salicylate-sodium—Blood urea increased—Mesalazine—Crohn's disease	0.000188	0.0117	CcSEcCtD
Salicylate-sodium—Ecchymosis—Mesalazine—Crohn's disease	0.00018	0.0112	CcSEcCtD
Salicylate-sodium—Disorientation—Mesalazine—Crohn's disease	0.000162	0.01	CcSEcCtD
Salicylate-sodium—Deafness—Mesalazine—Crohn's disease	0.000162	0.01	CcSEcCtD
Salicylate-sodium—Renal failure acute—Mesalazine—Crohn's disease	0.000157	0.00972	CcSEcCtD
Salicylate-sodium—Renal impairment—Mesalazine—Crohn's disease	0.000152	0.00943	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—PTGS2—Crohn's disease	0.000148	0.131	CrCbGaD
Salicylate-sodium—Lethargy—Mesalazine—Crohn's disease	0.000148	0.00916	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Mesalazine—Crohn's disease	0.000135	0.0084	CcSEcCtD
Salicylate-sodium—Necrosis—Prednisone—Crohn's disease	0.000134	0.00833	CcSEcCtD
Salicylate-sodium—Abscess—Prednisone—Crohn's disease	0.000133	0.00826	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Mesalazine—Crohn's disease	0.000132	0.00819	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—ALB—Crohn's disease	0.000132	0.117	CrCbGaD
Salicylate-sodium—Abdominal discomfort—Azathioprine—Crohn's disease	0.000131	0.00816	CcSEcCtD
Salicylate-sodium—Oedema—Mercaptopurine—Crohn's disease	0.000131	0.00812	CcSEcCtD
Salicylate-sodium—Abdominal distension—Mesalazine—Crohn's disease	0.000126	0.00781	CcSEcCtD
Salicylate-sodium—Salsalate—PTGS2—Crohn's disease	0.000126	0.111	CrCbGaD
Salicylate-sodium—Asthma—Mesalazine—Crohn's disease	0.000125	0.00775	CcSEcCtD
Salicylate-sodium—Dysphagia—Mesalazine—Crohn's disease	0.000125	0.00775	CcSEcCtD
Salicylate-sodium—Anorexia—Mercaptopurine—Crohn's disease	0.000125	0.00774	CcSEcCtD
Salicylate-sodium—Bronchospasm—Mesalazine—Crohn's disease	0.000123	0.00763	CcSEcCtD
Salicylate-sodium—Bronchitis—Mesalazine—Crohn's disease	0.00012	0.00746	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Mesalazine—Crohn's disease	0.00012	0.00743	CcSEcCtD
Salicylate-sodium—Decreased appetite—Mercaptopurine—Crohn's disease	0.000114	0.00706	CcSEcCtD
Salicylate-sodium—Weight increased—Mesalazine—Crohn's disease	0.000114	0.00706	CcSEcCtD
Salicylate-sodium—Ulcer—Prednisone—Crohn's disease	0.000111	0.00691	CcSEcCtD
Salicylate-sodium—Renal failure—Mesalazine—Crohn's disease	0.00011	0.0068	CcSEcCtD
Salicylate-sodium—Mesalazine—PTGS2—Crohn's disease	0.000109	0.0966	CrCbGaD
Salicylate-sodium—Epistaxis—Mesalazine—Crohn's disease	0.000105	0.00652	CcSEcCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000105	0.0628	CbGpPWpGaD
Salicylate-sodium—Erythema multiforme—Azathioprine—Crohn's disease	0.000104	0.00644	CcSEcCtD
Salicylate-sodium—Body temperature increased—Mercaptopurine—Crohn's disease	0.000103	0.00642	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Prednisone—Crohn's disease	0.000101	0.00624	CcSEcCtD
Salicylate-sodium—Fluid retention—Prednisone—Crohn's disease	0.0001	0.00621	CcSEcCtD
Salicylate-sodium—Hepatitis—Mesalazine—Crohn's disease	0.0001	0.00621	CcSEcCtD
Salicylate-sodium—Arrhythmia—Azathioprine—Crohn's disease	9.81e-05	0.00609	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mercaptopurine—Crohn's disease	9.64e-05	0.00599	CcSEcCtD
Salicylate-sodium—Oesophagitis—Prednisone—Crohn's disease	9.63e-05	0.00598	CcSEcCtD
Salicylate-sodium—Ecchymosis—Prednisone—Crohn's disease	9.53e-05	0.00591	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Mesalazine—Crohn's disease	9.46e-05	0.00587	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—Crohn's disease	9.39e-05	0.0832	CrCbGaD
Salicylate-sodium—Tinnitus—Mesalazine—Crohn's disease	9.32e-05	0.00579	CcSEcCtD
Salicylate-sodium—Sepsis—Prednisone—Crohn's disease	9.14e-05	0.00567	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mercaptopurine—Crohn's disease	8.96e-05	0.00556	CcSEcCtD
Salicylate-sodium—Erythema—Mesalazine—Crohn's disease	8.71e-05	0.0054	CcSEcCtD
Salicylate-sodium—Flatulence—Mesalazine—Crohn's disease	8.58e-05	0.00532	CcSEcCtD
Salicylate-sodium—Dysgeusia—Mesalazine—Crohn's disease	8.52e-05	0.00529	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Prednisone—Crohn's disease	8.43e-05	0.00523	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—ALB—Crohn's disease	8.36e-05	0.0741	CrCbGaD
Salicylate-sodium—Vomiting—Mercaptopurine—Crohn's disease	8.32e-05	0.00517	CcSEcCtD
Salicylate-sodium—Rash—Mercaptopurine—Crohn's disease	8.25e-05	0.00512	CcSEcCtD
Salicylate-sodium—Dermatitis—Mercaptopurine—Crohn's disease	8.25e-05	0.00512	CcSEcCtD
Salicylate-sodium—Vision blurred—Mesalazine—Crohn's disease	8.2e-05	0.00509	CcSEcCtD
Salicylate-sodium—Syncope—Mesalazine—Crohn's disease	7.81e-05	0.00485	CcSEcCtD
Salicylate-sodium—Lethargy—Prednisone—Crohn's disease	7.8e-05	0.00484	CcSEcCtD
Salicylate-sodium—Nausea—Mercaptopurine—Crohn's disease	7.78e-05	0.00483	CcSEcCtD
Salicylate-sodium—Infection—Azathioprine—Crohn's disease	7.75e-05	0.00481	CcSEcCtD
Salicylate-sodium—Salicylic acid—PTGS2—Crohn's disease	7.73e-05	0.0685	CrCbGaD
Salicylate-sodium—Palpitations—Mesalazine—Crohn's disease	7.69e-05	0.00477	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Mesalazine—Crohn's disease	7.65e-05	0.00475	CcSEcCtD
Salicylate-sodium—Chest pain—Mesalazine—Crohn's disease	7.41e-05	0.0046	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	7.41e-05	0.0444	CbGpPWpGaD
Salicylate-sodium—Anxiety—Mesalazine—Crohn's disease	7.39e-05	0.00458	CcSEcCtD
Salicylate-sodium—Irritability—Prednisone—Crohn's disease	7.3e-05	0.00453	CcSEcCtD
Salicylate-sodium—Hypotension—Azathioprine—Crohn's disease	7.29e-05	0.00452	CcSEcCtD
Salicylate-sodium—Confusional state—Mesalazine—Crohn's disease	7.16e-05	0.00445	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Mesalazine—Crohn's disease	7.1e-05	0.00441	CcSEcCtD
Salicylate-sodium—Oedema—Mesalazine—Crohn's disease	7.1e-05	0.00441	CcSEcCtD
Salicylate-sodium—Infection—Mesalazine—Crohn's disease	7.06e-05	0.00438	CcSEcCtD
Salicylate-sodium—Shock—Mesalazine—Crohn's disease	6.99e-05	0.00434	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Prednisone—Crohn's disease	6.96e-05	0.00432	CcSEcCtD
Salicylate-sodium—Tachycardia—Mesalazine—Crohn's disease	6.93e-05	0.0043	CcSEcCtD
Salicylate-sodium—Salicylic acid—ALB—Crohn's disease	6.89e-05	0.061	CrCbGaD
Salicylate-sodium—Hyperhidrosis—Mesalazine—Crohn's disease	6.87e-05	0.00426	CcSEcCtD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	6.78e-05	0.0406	CbGpPWpGaD
Salicylate-sodium—Anorexia—Mesalazine—Crohn's disease	6.77e-05	0.0042	CcSEcCtD
Salicylate-sodium—Abdominal distension—Prednisone—Crohn's disease	6.65e-05	0.00413	CcSEcCtD
Salicylate-sodium—Hypotension—Mesalazine—Crohn's disease	6.64e-05	0.00412	CcSEcCtD
Salicylate-sodium—Sweating increased—Prednisone—Crohn's disease	6.44e-05	0.004	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Azathioprine—Crohn's disease	6.43e-05	0.00399	CcSEcCtD
Salicylate-sodium—Paraesthesia—Mesalazine—Crohn's disease	6.38e-05	0.00396	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Azathioprine—Crohn's disease	6.38e-05	0.00396	CcSEcCtD
Salicylate-sodium—Dyspnoea—Mesalazine—Crohn's disease	6.33e-05	0.00393	CcSEcCtD
Salicylate-sodium—Somnolence—Mesalazine—Crohn's disease	6.32e-05	0.00392	CcSEcCtD
Salicylate-sodium—Dyspepsia—Mesalazine—Crohn's disease	6.25e-05	0.00388	CcSEcCtD
Salicylate-sodium—Decreased appetite—Mesalazine—Crohn's disease	6.18e-05	0.00383	CcSEcCtD
Salicylate-sodium—Abdominal pain—Azathioprine—Crohn's disease	6.17e-05	0.00383	CcSEcCtD
Salicylate-sodium—Body temperature increased—Azathioprine—Crohn's disease	6.17e-05	0.00383	CcSEcCtD
Salicylate-sodium—Fatigue—Mesalazine—Crohn's disease	6.13e-05	0.0038	CcSEcCtD
Salicylate-sodium—Pain—Mesalazine—Crohn's disease	6.08e-05	0.00377	CcSEcCtD
Salicylate-sodium—Constipation—Mesalazine—Crohn's disease	6.08e-05	0.00377	CcSEcCtD
Salicylate-sodium—Weight increased—Prednisone—Crohn's disease	6.02e-05	0.00373	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Mesalazine—Crohn's disease	5.85e-05	0.00363	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Prednisone—Crohn's disease	5.81e-05	0.00361	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Mesalazine—Crohn's disease	5.81e-05	0.00361	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Prednisone—Crohn's disease	5.78e-05	0.00359	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Azathioprine—Crohn's disease	5.75e-05	0.00357	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	5.68e-05	0.034	CbGpPWpGaD
Salicylate-sodium—Urticaria—Mesalazine—Crohn's disease	5.64e-05	0.0035	CcSEcCtD
Salicylate-sodium—Abdominal pain—Mesalazine—Crohn's disease	5.62e-05	0.00349	CcSEcCtD
Salicylate-sodium—Body temperature increased—Mesalazine—Crohn's disease	5.62e-05	0.00349	CcSEcCtD
Salicylate-sodium—Diarrhoea—Azathioprine—Crohn's disease	5.34e-05	0.00331	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	5.3e-05	0.0317	CbGpPWpGaD
Salicylate-sodium—Hallucination—Prednisone—Crohn's disease	5.26e-05	0.00327	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mesalazine—Crohn's disease	5.23e-05	0.00325	CcSEcCtD
Salicylate-sodium—Dizziness—Azathioprine—Crohn's disease	5.16e-05	0.0032	CcSEcCtD
Salicylate-sodium—Asthenia—Mesalazine—Crohn's disease	5.1e-05	0.00316	CcSEcCtD
Salicylate-sodium—Pruritus—Mesalazine—Crohn's disease	5.03e-05	0.00312	CcSEcCtD
Salicylate-sodium—Vomiting—Azathioprine—Crohn's disease	4.96e-05	0.00308	CcSEcCtD
Salicylate-sodium—Rash—Azathioprine—Crohn's disease	4.92e-05	0.00305	CcSEcCtD
Salicylate-sodium—Dermatitis—Azathioprine—Crohn's disease	4.91e-05	0.00305	CcSEcCtD
Salicylate-sodium—Headache—Azathioprine—Crohn's disease	4.89e-05	0.00303	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mesalazine—Crohn's disease	4.86e-05	0.00302	CcSEcCtD
Salicylate-sodium—Arrhythmia—Prednisone—Crohn's disease	4.73e-05	0.00293	CcSEcCtD
Salicylate-sodium—Dizziness—Mesalazine—Crohn's disease	4.7e-05	0.00292	CcSEcCtD
Salicylate-sodium—Nausea—Azathioprine—Crohn's disease	4.63e-05	0.00288	CcSEcCtD
Salicylate-sodium—Erythema—Prednisone—Crohn's disease	4.61e-05	0.00286	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	4.61e-05	0.0276	CbGpPWpGaD
Salicylate-sodium—Vomiting—Mesalazine—Crohn's disease	4.52e-05	0.0028	CcSEcCtD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	4.51e-05	0.027	CbGpPWpGaD
Salicylate-sodium—Rash—Mesalazine—Crohn's disease	4.48e-05	0.00278	CcSEcCtD
Salicylate-sodium—Dermatitis—Mesalazine—Crohn's disease	4.48e-05	0.00278	CcSEcCtD
Salicylate-sodium—Headache—Mesalazine—Crohn's disease	4.45e-05	0.00276	CcSEcCtD
Salicylate-sodium—Vision blurred—Prednisone—Crohn's disease	4.34e-05	0.00269	CcSEcCtD
Salicylate-sodium—Nausea—Mesalazine—Crohn's disease	4.22e-05	0.00262	CcSEcCtD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	4.2e-05	0.0252	CbGpPWpGaD
Salicylate-sodium—Syncope—Prednisone—Crohn's disease	4.13e-05	0.00256	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Prednisone—Crohn's disease	4.05e-05	0.00251	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisone—Crohn's disease	3.99e-05	0.00248	CcSEcCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	3.94e-05	0.0236	CbGpPWpGaD
Salicylate-sodium—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	3.94e-05	0.0236	CbGpPWpGaD
Salicylate-sodium—Anxiety—Prednisone—Crohn's disease	3.91e-05	0.00243	CcSEcCtD
Salicylate-sodium—Oedema—Prednisone—Crohn's disease	3.76e-05	0.00233	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisone—Crohn's disease	3.76e-05	0.00233	CcSEcCtD
Salicylate-sodium—Infection—Prednisone—Crohn's disease	3.73e-05	0.00232	CcSEcCtD
Salicylate-sodium—Shock—Prednisone—Crohn's disease	3.7e-05	0.0023	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisone—Crohn's disease	3.67e-05	0.00228	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	3.66e-05	0.0219	CbGpPWpGaD
Salicylate-sodium—Hyperhidrosis—Prednisone—Crohn's disease	3.63e-05	0.00226	CcSEcCtD
Salicylate-sodium—Anorexia—Prednisone—Crohn's disease	3.58e-05	0.00222	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisone—Crohn's disease	3.38e-05	0.00209	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	3.37e-05	0.0202	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Prednisone—Crohn's disease	3.31e-05	0.00205	CcSEcCtD
Salicylate-sodium—Decreased appetite—Prednisone—Crohn's disease	3.27e-05	0.00203	CcSEcCtD
Salicylate-sodium—Fatigue—Prednisone—Crohn's disease	3.24e-05	0.00201	CcSEcCtD
Salicylate-sodium—Constipation—Prednisone—Crohn's disease	3.21e-05	0.002	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Prednisone—Crohn's disease	3.1e-05	0.00192	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	3.09e-05	0.0185	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Prednisone—Crohn's disease	3.07e-05	0.00191	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	3e-05	0.0179	CbGpPWpGaD
Salicylate-sodium—Urticaria—Prednisone—Crohn's disease	2.99e-05	0.00185	CcSEcCtD
Salicylate-sodium—Body temperature increased—Prednisone—Crohn's disease	2.97e-05	0.00184	CcSEcCtD
Salicylate-sodium—Abdominal pain—Prednisone—Crohn's disease	2.97e-05	0.00184	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Prednisone—Crohn's disease	2.77e-05	0.00172	CcSEcCtD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	2.76e-05	0.0166	CbGpPWpGaD
Salicylate-sodium—Asthenia—Prednisone—Crohn's disease	2.7e-05	0.00167	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	2.67e-05	0.016	CbGpPWpGaD
Salicylate-sodium—Pruritus—Prednisone—Crohn's disease	2.66e-05	0.00165	CcSEcCtD
Salicylate-sodium—Diarrhoea—Prednisone—Crohn's disease	2.57e-05	0.0016	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	2.57e-05	0.0154	CbGpPWpGaD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	2.56e-05	0.0153	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	2.55e-05	0.0153	CbGpPWpGaD
Salicylate-sodium—Dizziness—Prednisone—Crohn's disease	2.49e-05	0.00154	CcSEcCtD
Salicylate-sodium—Vomiting—Prednisone—Crohn's disease	2.39e-05	0.00148	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	2.38e-05	0.0142	CbGpPWpGaD
Salicylate-sodium—Rash—Prednisone—Crohn's disease	2.37e-05	0.00147	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisone—Crohn's disease	2.37e-05	0.00147	CcSEcCtD
Salicylate-sodium—Headache—Prednisone—Crohn's disease	2.35e-05	0.00146	CcSEcCtD
Salicylate-sodium—Nausea—Prednisone—Crohn's disease	2.23e-05	0.00139	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	2.16e-05	0.0129	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	2.14e-05	0.0128	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	2.12e-05	0.0127	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	2.08e-05	0.0125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	2.04e-05	0.0122	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	1.82e-05	0.0109	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	1.79e-05	0.0107	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	1.68e-05	0.0101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	1.66e-05	0.00991	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	1.59e-05	0.00955	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.42e-05	0.00853	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	1.35e-05	0.00809	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	1.34e-05	0.008	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.24e-05	0.00744	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.22e-05	0.00731	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	1.18e-05	0.00706	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	1.1e-05	0.00657	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	1.07e-05	0.00642	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.04e-05	0.00621	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	1.04e-05	0.0062	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	9.86e-06	0.00591	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.69e-06	0.0058	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	9.45e-06	0.00566	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	9.06e-06	0.00543	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	8.73e-06	0.00523	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	8.43e-06	0.00505	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.24e-06	0.00493	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	8.22e-06	0.00492	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	8.16e-06	0.00489	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	8.13e-06	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.08e-06	0.00484	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	7.8e-06	0.00467	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	7.63e-06	0.00457	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.57e-06	0.00453	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	7.52e-06	0.0045	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	7.5e-06	0.00449	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	6.69e-06	0.00401	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.42e-06	0.00384	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	6.12e-06	0.00366	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.01e-06	0.0036	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	5.93e-06	0.00355	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	5.52e-06	0.0033	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLA2G4F—Crohn's disease	5.43e-06	0.00325	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	5.29e-06	0.00317	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	4.94e-06	0.00296	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	4.86e-06	0.00291	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTMR3—Crohn's disease	4.62e-06	0.00277	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RSPO3—Crohn's disease	4.5e-06	0.0027	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLA2G4F—Crohn's disease	4.31e-06	0.00258	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SEL1L—Crohn's disease	4.27e-06	0.00256	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	3.92e-06	0.00235	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	3.84e-06	0.0023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LTF—Crohn's disease	3.83e-06	0.00229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTMR3—Crohn's disease	3.67e-06	0.0022	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—FADS1—Crohn's disease	3.6e-06	0.00216	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GPX4—Crohn's disease	3.37e-06	0.00202	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GCKR—Crohn's disease	3.26e-06	0.00195	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	3.1e-06	0.00186	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GCKR—Crohn's disease	3.09e-06	0.00185	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—FADS1—Crohn's disease	2.86e-06	0.00171	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SLC11A1—Crohn's disease	2.73e-06	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPX4—Crohn's disease	2.68e-06	0.0016	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.61e-06	0.00156	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GCKR—Crohn's disease	2.58e-06	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RBX1—Crohn's disease	2.34e-06	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HSPA1B—Crohn's disease	2.34e-06	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.33e-06	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—UBE2D1—Crohn's disease	2.05e-06	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.04e-06	0.00122	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.85e-06	0.00111	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SMAD3—Crohn's disease	1.47e-06	0.000879	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—Crohn's disease	1.04e-06	0.000621	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TYK2—Crohn's disease	9.57e-07	0.000573	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JAK2—Crohn's disease	9.13e-07	0.000547	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—Crohn's disease	9.06e-07	0.000543	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD4—Crohn's disease	8.66e-07	0.000518	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—Crohn's disease	8.22e-07	0.000493	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—Crohn's disease	6.7e-07	0.000401	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—Crohn's disease	4.68e-07	0.00028	CbGpPWpGaD
